全球CRO转向Datatrak eTMF进行所有试验,降低成本,提高效率和合规性. A global CRO switched to Datatrak eTMF for all trials, cutting costs and improving efficiency and compliance.

一个全球临床研究组织已经更换了一家主要电子TMF供应商,代之以 " Datatrak eTMF " ,用于其所有世界范围的临床试验,理由是更好地融入了EDC和电子信息来源系统,单一信号接入,以及每年技术成本减少了100 000美元以上。 A global clinical research organization has replaced a major eTMF vendor with Datatrak eTMF for all its worldwide clinical trials, citing better integration with EDC and eSource systems, single-sign-on access, and reduced annual technology costs by over $100,000. 转换的目的是提高工作流程效率,遵守诸如21 CFR Part 11等条例,以及审判监督。 The switch aims to improve workflow efficiency, compliance with regulations like 21 CFR Part 11, and trial oversight. Datatrak eTMF是支持EDC、CTMS、ECONT和ePRO系统的统一平台的一部分,用于83个国家的10 000多个试验。 Datatrak eTMF is part of a unified platform supporting EDC, CTMS, eConsent, and ePRO systems, used in over 10,000 trials across 83 countries. 首席执行官期望审查时间加快,更加注重审判结果。 The CRO expects faster review times and more focus on trial outcomes.